 |
recombinant monoclonal antibody to human serum amyloid P component |
|---|---|
| Trade Name | |
| Orphan Indication | AL amyloidosis |
| USA Market Approval | USA |
| USA Designation Date | 2015-02-10 00:00:00 |
| Sponsor | Glaxo Group Limited, England d/b/a GlaxoSmithKline;980 Great West Road, Middlesex, TW8, 9GS; |
